NIH-funded research R03 grant

How cardiovascular genetics and APOE ε4 status affect amyloid levels in early Alzheimer's disease

Official title: Cardiovascular Genotype and APOE ε4 Carrier Status Interaction Effects on Amyloid Load in Pre-Clinical Alzheimer's Disease

Funded at Banner Health · NIH-10849838 · Data updated 2026-11-12

This study is looking at how certain genes and the presence of the APOE ε4 gene might affect the buildup of amyloid plaques in people who are at risk for Alzheimer's disease, especially those with conditions like high cholesterol and high blood pressure, to see if there are ways to protect against Alzheimer's.

More s Disease research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionBanner Health
NIH-funded
Lab location1 site (Phoenix, United States)
Project startJune 1, 2023
Project endMarch 31, 2026
Funding year2024
Award (this year)$89,442
NIH project number5R03AG077270-02
Project IDNIH-10849838 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are older adults who are APOE ε4 carriers and may have cardiovascular risk factors.

Less likely to help

Patients who do not have pre-clinical Alzheimer's disease or are not APOE ε4 carriers may not benefit from this research.

What this research studies

This research investigates the interaction between cardiovascular genetic factors and APOE ε4 carrier status in relation to amyloid load in individuals with pre-clinical Alzheimer's disease. It aims to understand how conditions like high cholesterol and hypertension may influence the development of Alzheimer's pathology, particularly the formation of amyloid plaques. By analyzing specific genetic markers, the study seeks to uncover potential protective factors against amyloid deposition and their implications for Alzheimer's risk. Patients may undergo genetic testing and assessments to determine their eligibility and potential involvement in the research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and potential interventions for preventing or delaying Alzheimer's disease in at-risk individuals.

How similar studies have gone: Previous studies have shown promising results in understanding the relationship between cardiovascular health and Alzheimer's disease, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Banner Health
    Phoenix, United States
    Active

Researchers

  • Principal investigator: Malek-Ahmadi, Michael — Banner Health
  • Study coordinator: Malek-Ahmadi, Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.